Smitha Jagadish
Smitha Jagadish is a prominent figure in the pharmaceutical industry, currently leading the rare diseases division at Bial, a Portuguese pharmaceutical company. She is known for her commitment to advancing therapies for rare diseases and played a crucial role in Bial's recent partnership with the Orphan Therapeutics Accelerator (OTXL), aiming to revive the development of promising clinical-stage drugs that were previously shelved. Her work emphasizes the importance of innovative solutions in addressing the challenges faced by patients with rare conditions.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Portugal:
Smitha Jagadish is responsible for the rare diseases area at Bial.
8